{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:49:14Z","timestamp":1794412154377,"version":"4.9.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Basic and Applied Basic Research Foundation","award":["2024A04J4811"],"award-info":[{"award-number":["2024A04J4811"]}]},{"name":"Hospital Fund of the First Affiliated Hospital of Guangdong Pharmaceutical University","award":["ZXYXTQJ202304"],"award-info":[{"award-number":["ZXYXTQJ202304"]}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2020A0505100058"],"award-info":[{"award-number":["2020A0505100058"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271225"],"award-info":[{"award-number":["32271225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Province Medical Products Administration","award":["2022TDZ19"],"award-info":[{"award-number":["2022TDZ19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03642-z","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T07:53:39Z","timestamp":1736841219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Zihao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Bei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Size","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"3","key":"3642_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"3642_CR2","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","volume":"17","author":"GT Gibney","year":"2016","unstructured":"Gibney GT, Weiner LM, Atkins MB. Predictive biomarkers for checkpoint inhibitor-based immunotherapy. Lancet Oncol. 2016;17(12):e542\u201351.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3642_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017;168(4):707\u201323.","journal-title":"Cell"},{"issue":"47","key":"3642_CR4","doi-asserted-by":"publisher","first-page":"e2205950","DOI":"10.1002\/adma.202205950","volume":"34","author":"J Zhang","year":"2022","unstructured":"Zhang J, Fan B, Cao G, Huang W, Jia F, Nie G, Wang H. Direct presentation of Tumor-Associated antigens to induce adaptive immunity by personalized dendritic cell-mimicking nanovaccines. Adv Mater. 2022;34(47):e2205950.","journal-title":"Adv Mater"},{"key":"3642_CR5","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3389\/fimmu.2018.03059","volume":"9","author":"C Fu","year":"2018","unstructured":"Fu C, Jiang A. Dendritic cells and CD8 T cell immunity in Tumor Microenvironment. Front Immunol. 2018;9:3059.","journal-title":"Front Immunol"},{"issue":"4","key":"3642_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccell.2018.03.008","volume":"33","author":"RH Vonderheide","year":"2018","unstructured":"Vonderheide RH. The Immune Revolution: a case for Priming, not checkpoint. Cancer Cell. 2018;33(4):563\u20139.","journal-title":"Cancer Cell"},{"issue":"3","key":"3642_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","volume":"74","author":"J Goc","year":"2014","unstructured":"Goc J, Germain C, Vo-Bourgais TK, Lupo A, Klein C, Knockaert S, de Chaisemartin L, Ouakrim H, Becht E, Alifano M, et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8\u2009+\u2009T cells. Cancer Res. 2014;74(3):705\u201315.","journal-title":"Cancer Res"},{"issue":"11","key":"3642_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.201510-2031OC","volume":"194","author":"A Mansuet-Lupo","year":"2016","unstructured":"Mansuet-Lupo A, Alifano M, P\u00e9cuchet N, Biton J, Becht E, Goc J, Germain C, Ouakrim H, R\u00e9gnard JF, Cremer I, et al. Intratumoral Immune Cell densities are Associated with Lung Adenocarcinoma Gene alterations. Am J Respir Crit Care Med. 2016;194(11):1403\u201312.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3642_CR9","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, Nelson AE, Loo K, Kumar R, Rosenblum MD, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat Med. 2018;24(8):1178\u201391.","journal-title":"Nat Med"},{"issue":"9","key":"3642_CR10","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1182\/blood-2005-08-3419","volume":"107","author":"S Hanabuchi","year":"2006","unstructured":"Hanabuchi S, Watanabe N, Wang YH, Wang YH, Ito T, Shaw J, Cao W, Qin FX, Liu YJ. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood. 2006;107(9):3617\u201323.","journal-title":"Blood"},{"issue":"4","key":"3642_CR11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/eji.200323676","volume":"33","author":"M Salio","year":"2003","unstructured":"Salio M, Cella M, Vermi W, Facchetti F, Palmowski MJ, Smith CL, Shepherd D, Colonna M, Cerundolo V. Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur J Immunol. 2003;33(4):1052\u201362.","journal-title":"Eur J Immunol"},{"issue":"1","key":"3642_CR12","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s41467-019-09762-1","volume":"10","author":"XC Zhang","year":"2019","unstructured":"Zhang XC, Wang J, Shao GG, Wang Q, Qu X, Wang B, Moy C, Fan Y, Albertyn Z, Huang X, et al. Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients. Nat Commun. 2019;10(1):1772.","journal-title":"Nat Commun"},{"issue":"1","key":"3642_CR13","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","volume":"15","author":"M De Zuani","year":"2024","unstructured":"De Zuani M, Xue H, Park JS, Dentro SC, Seferbekova Z, Tessier J, Curras-Alonso S, Hadjipanayis A, Athanasiadis EI, Gerstung M, et al. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer. Nat Commun. 2024;15(1):4388.","journal-title":"Nat Commun"},{"issue":"1","key":"3642_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.chest.2023.01.019","volume":"164","author":"K Mahmood","year":"2023","unstructured":"Mahmood K, Jampani P, Clarke JM, Wolf S, Wang X, Wahidi MM, Giovacchini CX, Dorry M, Shofer SL, Shier J, et al. High yield of Pleural Cell-Free DNA for diagnosis of oncogenic mutations in Lung Adenocarcinoma. Chest. 2023;164(1):252\u201361.","journal-title":"Chest"},{"issue":"19","key":"3642_CR15","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.7150\/thno.34070","volume":"9","author":"L Tong","year":"2019","unstructured":"Tong L, Ding N, Tong X, Li J, Zhang Y, Wang X, Xu X, Ye M, Li C, Wu X, et al. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics. 2019;9(19):5532\u201341.","journal-title":"Theranostics"},{"issue":"5617","key":"3642_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1084564","volume":"300","author":"FS Collins","year":"2003","unstructured":"Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science. 2003;300(5617):286\u201390.","journal-title":"Science"},{"issue":"9","key":"3642_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrg.2016.86","volume":"17","author":"EA Ashley","year":"2016","unstructured":"Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17(9):507\u201322.","journal-title":"Nat Rev Genet"},{"issue":"6633","key":"3642_CR18","doi-asserted-by":"publisher","first-page":"eabg2752","DOI":"10.1126\/science.abg2752","volume":"379","author":"M He","year":"2023","unstructured":"He M, Roussak K, Ma F, Borcherding N, Garin V, White M, Schutt C, Jensen TI, Zhao Y, Iberg CA, et al. CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses. Science. 2023;379(6633):eabg2752.","journal-title":"Science"},{"issue":"6","key":"3642_CR19","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","volume":"49","author":"CS Garris","year":"2018","unstructured":"Garris CS, Arlauckas SP, Kohler RH, Trefny MP, Garren S, Piot C, Engblom C, Pfirschke C, Siwicki M, Gungabeesoon J, et al. Successful Anti-PD-1 Cancer Immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12. Immunity. 2018;49(6):1148\u2013e11611147.","journal-title":"Immunity"},{"issue":"3","key":"3642_CR20","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1002\/ctm2.350","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen Z, Huang Y, Hu Z, Zhao M, Li M, Bi G, Zheng Y, Liang J, Lu T, Jiang W, et al. Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma. Clin Transl Med. 2021;11(3):e350.","journal-title":"Clin Transl Med"},{"issue":"5","key":"3642_CR21","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","volume":"182","author":"A Maynard","year":"2020","unstructured":"Maynard A, McCoach CE, Rotow JK, Harris L, Haderk F, Kerr DL, Yu EA, Schenk EL, Tan W, Zee A, et al. Therapy-Induced Evolution of Human Lung Cancer revealed by single-cell RNA sequencing. Cell. 2020;182(5):1232\u2013e12511222.","journal-title":"Cell"},{"issue":"1","key":"3642_CR22","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, Lee JI, Suh YL, Ku BM, Eum HH, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.","journal-title":"Nat Commun"},{"issue":"W1","key":"3642_CR23","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"3642_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"3642_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, Wang L, Lu T, Zhang Y, Sun Z, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816.","journal-title":"Nat Commun"},{"issue":"3","key":"3642_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/bioinformatics\/btu660","volume":"31","author":"P Bastien","year":"2015","unstructured":"Bastien P, Bertrand F, Meyer N, Maumy-Bertrand M. Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data. Bioinformatics. 2015;31(3):397\u2013404.","journal-title":"Bioinformatics"},{"issue":"1","key":"3642_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Saut\u00e8s-Fridman C, Fridman WH, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"1","key":"3642_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"key":"3642_CR29","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"7","key":"3642_CR30","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S2352-3026(22)00134-X","volume":"9","author":"Y Song","year":"2022","unstructured":"Song Y, Liu Y, Li ZM, Li L, Su H, Jin Z, Zuo X, Wu J, Zhou H, Li K, et al. SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial. Lancet Haematol. 2022;9(7):e493\u2013503.","journal-title":"Lancet Haematol"},{"issue":"17","key":"3642_CR31","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1158\/0008-5472.CAN-19-3782","volume":"80","author":"F Li","year":"2020","unstructured":"Li F, Ng WL, Luster TA, Hu H, Sviderskiy VO, Dowling CM, Hollinshead KER, Zouitine P, Zhang H, Huang Q, et al. Epigenetic CRISPR screens identify Npm1 as a therapeutic vulnerability in Non-small Cell Lung Cancer. Cancer Res. 2020;80(17):3556\u201367.","journal-title":"Cancer Res"},{"issue":"3","key":"3642_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1158\/2159-8290.CD-20-0519","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Yuan S, Norgard RJ, Yan F, Sun YH, Kim IK, Merrell AJ, Sela Y, Jiang Y, Bhanu NV, et al. Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor regulates the Tumor Immune Microenvironment in Pancreatic Cancer. Cancer Discov. 2021;11(3):736\u201353.","journal-title":"Cancer Discov"},{"issue":"18","key":"3642_CR33","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The Tumor Microenvironment innately modulates Cancer Progression. Cancer Res. 2019;79(18):4557\u201366.","journal-title":"Cancer Res"},{"issue":"29","key":"3642_CR34","doi-asserted-by":"publisher","first-page":"e2203040","DOI":"10.1002\/advs.202203040","volume":"9","author":"Z Ou","year":"2022","unstructured":"Ou Z, Lin S, Qiu J, Ding W, Ren P, Chen D, Wang J, Tong Y, Wu D, Chen A, et al. Single-nucleus RNA sequencing and spatial transcriptomics reveal the immunological microenvironment of cervical squamous cell carcinoma. Adv Sci (Weinh). 2022;9(29):e2203040.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"3642_CR35","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41419-020-03042-3","volume":"11","author":"M Wang","year":"2020","unstructured":"Wang M, Cai Y, Peng Y, Xu B, Hui W, Jiang Y. Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity. Cell Death Dis. 2020;11(10):896.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3642_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.immuni.2019.08.012","volume":"51","author":"JG Abelin","year":"2019","unstructured":"Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, Creech AL, Serrano LR, Nasir G, Nasrullah Y, et al. Defining HLA-II Ligand Processing and binding rules with Mass Spectrometry enhances Cancer Epitope Prediction. Immunity. 2019;51(4):766\u2013e779717.","journal-title":"Immunity"},{"key":"3642_CR37","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3389\/fimmu.2018.02472","volume":"9","author":"J Grabowska","year":"2018","unstructured":"Grabowska J, Lopez-Venegas MA, Affandi AJ, den Haan JMM. CD169(+) macrophages capture and dendritic cells Instruct: the interplay of the gatekeeper and the General of the Immune System. Front Immunol. 2018;9:2472.","journal-title":"Front Immunol"},{"issue":"7808","key":"3642_CR38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41586-020-2282-0","volume":"581","author":"LX Heinz","year":"2020","unstructured":"Heinz LX, Lee J, Kapoor U, Kartnig F, Sedlyarov V, Papakostas K, C\u00e9sar-Razquin A, Essletzbichler P, Goldmann U, Stefanovic A, et al. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature. 2020;581(7808):316\u201322.","journal-title":"Nature"},{"key":"3642_CR39","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3389\/fimmu.2019.02160","volume":"10","author":"VM Harris","year":"2019","unstructured":"Harris VM, Koelsch KA, Kurien BT, Harley ITW, Wren JD, Harley JB, Scofield RH. Characterization of cxorf21 provides Molecular Insight into Female-Bias Immune response in SLE pathogenesis. Front Immunol. 2019;10:2160.","journal-title":"Front Immunol"},{"issue":"2","key":"3642_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/gcc.20069","volume":"41","author":"AM Clark","year":"2004","unstructured":"Clark AM, Reynolds SH, Anderson M, Wiest JS. Mutational activation of the MAP3K8 protooncogene in lung cancer. Genes Chromosomes Cancer. 2004;41(2):99\u2013108.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"3642_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12967-020-02233-y","volume":"18","author":"X Shi","year":"2020","unstructured":"Shi X, Li R, Dong X, Chen AM, Liu X, Lu D, Feng S, Wang H, Cai K. IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis. J Transl Med. 2020;18(1):55.","journal-title":"J Transl Med"},{"issue":"5","key":"3642_CR42","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jhep.2010.05.019","volume":"53","author":"YF Xu","year":"2010","unstructured":"Xu YF, Yi Y, Qiu SJ, Gao Q, Li YW, Dai CX, Cai MY, Ju MJ, Zhou J, Zhang BH, et al. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J Hepatol. 2010;53(5):872\u20139.","journal-title":"J Hepatol"},{"key":"3642_CR43","doi-asserted-by":"publisher","first-page":"101562","DOI":"10.1016\/j.mcp.2020.101562","volume":"52","author":"K Hu","year":"2020","unstructured":"Hu K, Qin X, Shao Y, Zhou Y, Ye G, Xu S. Circular RNA MTO1 suppresses tumorigenesis of gastric carcinoma by sponging mir-3200-5p and targeting PEBP1. Mol Cell Probes. 2020;52:101562.","journal-title":"Mol Cell Probes"},{"issue":"21","key":"3642_CR44","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1038\/sj.onc.1208435","volume":"24","author":"S Park","year":"2005","unstructured":"Park S, Yeung ML, Beach S, Shields JM, Yeung KC. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene. 2005;24(21):3535\u201340.","journal-title":"Oncogene"},{"key":"3642_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.abb.2016.09.007","volume":"610","author":"Q Zou","year":"2016","unstructured":"Zou Q, Wu H, Fu F, Yi W, Pei L, Zhou M. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2. Arch Biochem Biophys. 2016;610:25\u201332.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"3642_CR46","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.surg.2003.12.013","volume":"136","author":"L Zhang","year":"2004","unstructured":"Zhang L, Fu Z, Binkley C, Giordano T, Burant CF, Logsdon CD, Simeone DM. Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery. 2004;136(3):708\u201315.","journal-title":"Surgery"},{"issue":"1","key":"3642_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000236595","volume":"32","author":"J Hellmann","year":"2010","unstructured":"Hellmann J, Rommelspacher H, M\u00fchlbauer E, Wernicke C. Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells. Dev Neurosci. 2010;32(1):33\u201346.","journal-title":"Dev Neurosci"},{"issue":"40","key":"3642_CR48","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1038\/onc.2009.214","volume":"28","author":"S Baritaki","year":"2009","unstructured":"Baritaki S, Chapman A, Yeung K, Spandidos DA, Palladino M, Bonavida B. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of snail repression and RKIP induction. Oncogene. 2009;28(40):3573\u201385.","journal-title":"Oncogene"},{"issue":"2","key":"3642_CR49","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/labinvest.2017.104","volume":"98","author":"I Khan","year":"2018","unstructured":"Khan I, Steeg PS. Metastasis suppressors: functional pathways. Lab Invest. 2018;98(2):198\u2013210.","journal-title":"Lab Invest"},{"issue":"19","key":"3642_CR50","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1158\/0008-5472.CAN-14-3394","volume":"75","author":"C Frankenberger","year":"2015","unstructured":"Frankenberger C, Rabe D, Bainer R, Sankarasharma D, Chada K, Krausz T, Gilad Y, Becker L, Rosner MR. Metastasis suppressors regulate the Tumor Microenvironment by blocking recruitment of Prometastatic Tumor-Associated macrophages. Cancer Res. 2015;75(19):4063\u201373.","journal-title":"Cancer Res"},{"issue":"13","key":"3642_CR51","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.21037\/atm-20-7936","volume":"9","author":"C Ma","year":"2021","unstructured":"Ma C, Li F, Luo H. Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma. Ann Transl Med. 2021;9(13):1058.","journal-title":"Ann Transl Med"},{"key":"3642_CR52","doi-asserted-by":"publisher","first-page":"1072589","DOI":"10.3389\/fphar.2022.1072589","volume":"13","author":"T Cheng","year":"2022","unstructured":"Cheng T, Shan G, Yang H, Gu J, Lu C, Xu F, Ge D. Development of a ferroptosis-based model to predict prognosis, tumor microenvironment, and drug response for lung adenocarcinoma with weighted genes co-expression network analysis. Front Pharmacol. 2022;13:1072589.","journal-title":"Front Pharmacol"},{"issue":"17","key":"3642_CR53","doi-asserted-by":"publisher","first-page":"17515","DOI":"10.1074\/jbc.M313816200","volume":"279","author":"D Chatterjee","year":"2004","unstructured":"Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, et al. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem. 2004;279(17):17515\u201323.","journal-title":"J Biol Chem"},{"issue":"8","key":"3642_CR54","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","volume":"25","author":"A Mondino","year":"2004","unstructured":"Mondino A, Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 2004;25(8):450\u20135.","journal-title":"Trends Immunol"},{"issue":"12","key":"3642_CR55","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.2174\/138945011797635902","volume":"12","author":"IK Lund","year":"2011","unstructured":"Lund IK, Illemann M, Thurison T, Christensen IJ, H\u00f8yer-Hansen G. uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy. Curr Drug Targets. 2011;12(12):1744\u201360.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"3642_CR56","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1023\/A:1011980313237","volume":"18","author":"K Ichiki","year":"2000","unstructured":"Ichiki K, Mitani N, Doki Y, Hara H, Misaki T, Saiki I. Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer. Clin Exp Metastasis. 2000;18(7):539\u201345.","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"3642_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.leukres.2013.01.012","volume":"37","author":"P Ye","year":"2013","unstructured":"Ye P, Zhao L, Gonda TJ. The MYB oncogene can suppress apoptosis in acute myeloid leukemia cells by transcriptional repression of DRAK2 expression. Leuk Res. 2013;37(5):595\u2013601.","journal-title":"Leuk Res"},{"key":"3642_CR58","doi-asserted-by":"crossref","unstructured":"Szoltysek K, Ciardullo C, Zhou P, Walaszczyk A, Willmore E, Rand V, Marshall S, Hall A, C JH, Eswaran J et al. DAP kinase-related apoptosis-inducing protein kinase 2 (DRAK2) is a Key Regulator and molecular marker in chronic lymphocytic leukemia. Int J Mol Sci 2020, 21(20).","DOI":"10.3390\/ijms21207663"},{"issue":"3","key":"3642_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.bjc.6605144","volume":"101","author":"GA Doherty","year":"2009","unstructured":"Doherty GA, Byrne SM, Austin SC, Scully GM, Sadlier DM, Neilan TG, Kay EW, Murray FE, Fitzgerald DJ. Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer. Br J Cancer. 2009;101(3):483\u201391.","journal-title":"Br J Cancer"},{"issue":"2","key":"3642_CR60","doi-asserted-by":"publisher","first-page":"e0263311","DOI":"10.1371\/journal.pone.0263311","volume":"17","author":"X Shi","year":"2022","unstructured":"Shi X, Zhou Q, Huang B, Xia S, Jiang Y, Fang S, Lin J. Prognostic and immune-related value of STK17B in skin cutaneous melanoma. PLoS ONE. 2022;17(2):e0263311.","journal-title":"PLoS ONE"},{"issue":"2","key":"3642_CR61","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41419-018-0262-1","volume":"9","author":"Y Lan","year":"2018","unstructured":"Lan Y, Han J, Wang Y, Wang J, Yang G, Li K, Song R, Zheng T, Liang Y, Pan S, et al. STK17B promotes carcinogenesis and metastasis via AKT\/GSK-3\u03b2\/Snail signaling in hepatocellular carcinoma. Cell Death Dis. 2018;9(2):236.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3642_CR62","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.celrep.2012.09.028","volume":"2","author":"KM Yang","year":"2012","unstructured":"Yang KM, Kim W, Bae E, Gim J, Weist BM, Jung Y, Hyun JS, Hernandez JB, Leem SH, Park T, et al. DRAK2 participates in a negative feedback loop to control TGF-\u03b2\/Smads signaling by binding to type I TGF-\u03b2 receptor. Cell Rep. 2012;2(5):1286\u201399.","journal-title":"Cell Rep"},{"key":"3642_CR63","doi-asserted-by":"publisher","first-page":"708294","DOI":"10.3389\/fonc.2021.708294","volume":"11","author":"J Dai","year":"2021","unstructured":"Dai J, Jiang M, He K, Wang H, Chen P, Guo H, Zhao W, Lu H, He Y, Zhou C. DNA damage response and repair gene alterations increase Tumor Mutational Burden and promote poor prognosis of Advanced Lung Cancer. Front Oncol. 2021;11:708294.","journal-title":"Front Oncol"},{"issue":"1","key":"3642_CR64","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1038\/s41467-021-25894-9","volume":"12","author":"G Han","year":"2021","unstructured":"Han G, Yang G, Hao D, Lu Y, Thein K, Simpson BS, Chen J, Sun R, Alhalabi O, Wang R, et al. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nat Commun. 2021;12(1):5606.","journal-title":"Nat Commun"},{"key":"3642_CR65","doi-asserted-by":"publisher","first-page":"102227","DOI":"10.1016\/j.ctrv.2021.102227","volume":"101","author":"CL Gerard","year":"2021","unstructured":"Gerard CL, Delyon J, Wicky A, Homicsko K, Cuendet MA, Michielin O. Turning tumors from cold to inflamed to improve immunotherapy response. Cancer Treat Rev. 2021;101:102227.","journal-title":"Cancer Treat Rev"},{"key":"3642_CR66","doi-asserted-by":"publisher","first-page":"107438","DOI":"10.1016\/j.pharmthera.2019.107438","volume":"206","author":"WJ Liu","year":"2020","unstructured":"Liu WJ, Du Y, Wen R, Yang M, Xu J. Drug resistance to targeted therapeutic strategies in non-small cell lung cancer. Pharmacol Ther. 2020;206:107438.","journal-title":"Pharmacol Ther"},{"issue":"614","key":"3642_CR67","doi-asserted-by":"publisher","first-page":"eabg6428","DOI":"10.1126\/scitranslmed.abg6428","volume":"13","author":"KR Zhang","year":"2021","unstructured":"Zhang KR, Zhang YF, Lei HM, Tang YB, Ma CS, Lv QM, Wang SY, Lu LM, Shen Y, Chen HZ, et al. Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer. Sci Transl Med. 2021;13(614):eabg6428.","journal-title":"Sci Transl Med"},{"issue":"6","key":"3642_CR68","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1200\/JCO.21.01845","volume":"40","author":"A Passaro","year":"2022","unstructured":"Passaro A, Brahmer J, Antonia S, Mok T, Peters S. Managing resistance to Immune checkpoint inhibitors in Lung Cancer: treatment and novel strategies. J Clin Oncol. 2022;40(6):598\u2013610.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3642_CR69","first-page":"92","volume":"13","author":"Q Chen","year":"2021","unstructured":"Chen Q, Sun T, Jiang C. Recent advancements in Nanomedicine for \u2018Cold\u2019 Tumor Immunotherapy. Nanomicro Lett. 2021;13(1):92.","journal-title":"Nanomicro Lett"},{"issue":"6","key":"3642_CR70","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41379-018-0193-5","volume":"32","author":"L Li","year":"2019","unstructured":"Li L, Sun R, Miao Y, Tran T, Adams L, Roscoe N, Xu B, Manyam GC, Tan X, Zhang H, et al. PD-1\/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program. Mod Pathol. 2019;32(6):741\u201354.","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"3642_CR71","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1093\/annonc\/12.suppl_1.S81","volume":"12","author":"S Scholl","year":"2001","unstructured":"Scholl S, Beuzeboc P, Pouillart P. Targeting HER2 in other tumor types. Ann Oncol. 2001;12(Suppl 1):S81\u201387.","journal-title":"Ann Oncol"},{"key":"3642_CR72","doi-asserted-by":"crossref","unstructured":"Yang K, Li C, Liu Y, Gu X, Jiang L, Shi L. Prognostic and immunotherapeutic roles of KRAS in Pan-cancer. Cells 2022, 11(9).","DOI":"10.3390\/cells11091427"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03642-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03642-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03642-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T19:44:53Z","timestamp":1736883893000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03642-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3642"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03642-z","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in accordance with the Declaration of Helsinki and was approved by the Human Ethics Committee of Guangdong Pharmaceutical University\u2019s First Affiliated Hospital (approval No. 69, 2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}